Hua Medicine

About:

Hua Medicine is a clinical-stage, innovative drug development company in China.

Website: https://www.huamedicine.com

Top Investors: F-Prime Capital, ARCH Venture Partners, Fidelity, GIC, Venrock

Description:

Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.

Total Funding Amount:

$242M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2010-01-01

Contact Email:

BD(AT)huamedicine.com

Founders:

John Choi, Li Chen

Number of Employees:

101-250

Last Funding Date:

2018-03-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai